Search results
Results from the WOW.Com Content Network
The 1998–1999 Malaysia Nipah virus outbreak occurred from September 1998 to May 1999 in the states of Perak, Negeri Sembilan and Selangor in Malaysia. A total of 265 cases of acute encephalitis with 105 deaths caused by the virus were reported in the three states throughout the outbreak. [ 1 ]
Nipah virus outbreaks have been reported in Malaysia, Singapore, Bangladesh and India. The area is known as the Nipah Belt. The highest mortality due to Nipah virus infection was found in Bangladesh, [citation needed] where outbreaks are typically seen in winter. [24] Nipah virus was first seen in 1998 in
The Nipah virus has been classified by the Centers for Disease Control and Prevention as a Category C agent. [24] Nipah virus is one of several viruses identified by WHO as a potential cause of future epidemics in a new plan developed after the Ebola epidemic for urgent research and development toward new diagnostic tests, vaccines and medicines.
Tioman virus is a paramyxovirus first isolated from the urine of island fruit bats (Pteropus hypomelanus) on Tioman Island, Malaysia in 2000. The virus was discovered during efforts to identify the natural host of Nipah virus which was responsible for a large outbreak of encephalitic illness in humans and pigs in Malaysia and Singapore in 1998–99.
MySejahtera was developed by Entomo Malaysia (formerly KPISoft Malaysia), a local developer founded by Anuar Rozhan and Raveenderan Ramamoothie, [1] with strategic cooperation from the National Security Council (NSC), the Ministry of Health (MOH), the Malaysian Administrative Modernisation and Management Planning Unit (MAMPU), the Malaysian Communications and Multimedia Commission (MCMC), and ...
Since the Nipah virus outbreak in 1999, the Malaysian Health Ministry has implemented measures to better protect the population from infectious disease threats. During the Severe Acute Respiratory Syndrome (SARS) outbreak and the H5N1 (bird flu) outbreak in 2004, Malaysia demonstrated its preparedness to handle such crises.
Malaysia has granted conditional approval for the COVID-19 vaccine made by Pfizer and BioNTech to be used as a booster shot, the health ministry said on Friday. The approval allows the vaccine to ...
The local vaccine testing will be conducted in UM's TIDREC laboratory, which is one of Malaysia's modular biosafety level 3 (BSL3) facilities previously used to study highly pathogenic agents such as MERS coronavirus and Nipah virus with the vaccines to be firstly tested on the infectious bronchitis virus (IBV), which is an avian coronavirus ...